Construction of intertypic chimeric dengue viruses by substitution of structural protein genes.
Dengue virus contains an 11-kilobase positive-strand RNA genome that codes for, in one open reading frame, three structural proteins (capsid, premembrane, and envelope), followed by seven nonstructural proteins. The structural protein genes of a full-length cDNA clone of type 4 dengue virus were replaced with the corresponding genes of dengue 1 or dengue 2 to create intertypic chimeric cDNA. The RNA transcripts made from these templates were infectious when transfected into permissive cells in culture. Progeny of chimeric cDNA produced apparently authentic dengue 1 or dengue 2 structural proteins, together with dengue 4 nonstructural proteins, and as a consequence exhibited type 1 or type 2 serological specificity. Both of the chimeras ultimately grew to the same titer as their type 1 or type 2 parent, but the type 2/type 4 chimera grew very slowly. This chimera also produced small plaques; in contrast, the type 1/type 4 chimera produced normal size plaques. The type 2/type 4 chimera retained the mouse neurovirulence of the dengue 2 virus, which was the source of its structural protein genes. Each of the mice inoculated intracerebrally with the chimera died, but survival time was prolonged. The retardation of replication of the type 2/type 4 chimeric virus suggests that this virus and possibly other intertypic dengue virus chimeras with similar properties should be examined for attenuation in primates and possible usefulness in a live dengue virus vaccine for humans.
Molecular Viral Biology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
M
M
Bray
C J
CJ
Lai
D000818:Animals; D000911:Antibodies, Monoclonal; D000956:Antigens, Viral / Q000032:analysis; D001921:Brain / Q000382:microbiology; D002460:Cell Line; D002678:Chimera; D003001:Cloning, Molecular; D009033:Culicidae; D004279:DNA, Viral / Q000235:genetics / Q000302:isolation & purification; D003716:Dengue Virus / Q000235:genetics* / Q000302:isolation & purification; D005814:Genes, Viral; D005822:Genetic Vectors; D006682:HLA-DP Antigens / Q000235:genetics; D059867:HLA-DP alpha-Chains; D051379:Mice; D010957:Plasmids; D012367:RNA, Viral / Q000235:genetics; D014162:Transfection; D015678:Viral Structural Proteins / Q000235:genetics*
D000911:Antibodies, Monoclonal; D000956:Antigens, Viral; D004279:DNA, Viral; D006682:HLA-DP Antigens; D059867:HLA-DP alpha-Chains; C071695:HLA-DPA antigen; D012367:RNA, Viral; D015678:Viral Structural Proteins